Relypsa, Inc. (NASDAQ:RLYP) went higher by +0.28% to close at $ 32.02. The company exchanged total volume of 8.09 million shares throughout course of last trade however it holds an average trading capacity of 3.77 million shares. Shares of company began trading at $31.98 climbed to high of $32.12 touched the low of $31.93.
The company is trading above its 50-day moving averages of 20.74 and up from 200-day moving averages of 17.81. The firm has price to book ratio of 7.75 and its price to sale ratio was 46.19.
The average true range of Relypsa, Inc.’s (RLYP) is recorded at 1.42 and the relative strength index of the stock stands 83.67. The stock price is going above to its 52 week low with 212.09% and lagging behind from its 52 week high with -8.51%. Analyst recommendation for this stock stands at 2.10. A look on the firm performance, its monthly performance is 101.51% and a quarterly performance of 77.49%. The stock price is trading upbeat from its 200 days moving average with 67.95% and up from 50 days moving average with 65.22%.
According to ZACKS data, different Brokerage Firms rated the stock about their BUY, SELL or HOLD recommendations. 1 Month Ago, shares have been suggested as “BUY” from “2” brokerage firms and recommended as “Strong Buy” by “0” brokerage firms. 1” brokerage firms have issued “Sell” rating for the company and “Strong Sell” rating was issued by “1.66” brokerage firms. “0” brokerage firms have rated the company as a “Hold”. The Corporation has average brokerage recommendation (ABR) of 0 based on consensus of the brokerage firms issuing ratings.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) surged +4.22% and closed the trade at $ 415.09. The company recorded a trading capacity of 1 million shares above its three months average daily volume of 897.08 thousand shares. During the last trade, shares reached to high price of $416.00 and touched the low price of $399.00. The stock’s 50-day moving average is noted at $368.54 and its 200-day moving average is stands at $391.78.
Additionally, the company has a PE ratio of 65.81 and has EPS of 6.31. The company has market capitalization of $43.29B.
Regeneron Pharmaceuticals, Inc.’s (REGN) has price-to-cash ratio of 51.12 and price to sale ratio of 9.79. The company net profit margin is 16.40% and gross profit margin is 90.50%. A look on the firm performance, its monthly performance is 25.39% and a quarterly performance of 6.36%. The stock price is moving up from its 20 days moving average with 11.56% and isolated positively from 50 days moving average with 10.36%.